China Digital Therapeutics Market Analysis Report 2022 to 2030

China Digital Therapeutics Market Analysis

$ 3999

China Digital Therapeutics Market is at around $0.5 Bn in 2023 and is projected to reach $2.92 Bn in 2030, exhibiting a CAGR of 28.7 % during the forecast period. The market is expanding due to rising chronic diseases, rising healthcare awareness, and government support. The market is dominated by key players like Alibaba Health, WeDoctor, Omada Health Inc., 2Morrow Inc., Livongo Health Inc., WellDoc, Propeller Health, Canary Health, Noom Inc., Akili Interactive Labs Inc., and HYGIEIA.

ID: IN10CNDH006 CATEGORY: Digital Health GEOGRAPHY: China AUTHOR: Aneri Parekh

Buy Now

China Digital Therapeutics Market Executive Summary

China Digital Therapeutics Market is at around $0.5 Bn in 2023 and is projected to reach $2.92 Bn in 2030, exhibiting a CAGR of 28.7 % during the forecast period.

With its emphasis on utilizing digital technologies, such as software and mobile apps, to deliver evidence-based treatment interventions for a range of medical diseases, the Chinese market for digital therapeutics is expanding. As the healthcare industry is expanding quickly and adopting digital technology more widely, this market includes cutting-edge solutions intended to improve patient outcomes, increase treatment adherence, and offer affordable substitutes for conventional therapeutic methods. China's dedication to promoting healthcare through technology-driven interventions is demonstrated by the country's fast expansion of its healthcare system and its integration of digital therapies.

The growing awareness of digital health solutions is fueling the quick expansion of the digital therapeutics industry in China. The adoption of digital treatments in the nation is being driven mostly by technological improvements, government backing, and the growing prevalence of chronic diseases. To take advantage of this expanding industry, major firms are proactively forming alliances and working together.

The market for digital therapeutics has shown incredible growth, with revenue reaching $6.2 Bn globally in 2023. This industry has grown significantly, which is a result of the profound transformation that modern technology and cost-effective production methods have sparked. As a result, the healthcare sector is using digital treatments increasingly. As the market's present trend suggests that further changes may be in store, additional innovations are anticipated to support the industry's continued success.

Using its broad healthcare network and e-commerce experience, Alibaba Health is a prominent player in the Chinese digital therapeutics sector, providing a range of digital therapeutics solutions. The company's main areas of focus include lifestyle treatments, mental health, and chronic disease management. Alibaba Health has a substantial reach to prospective users of digital therapies due to its platform's more than 250 Mn active users.

China digital therapeutics market

Market Dynamics

Market Growth Drivers:

Growing Healthcare Awareness: Chinese people are growing more conscious of the value of digital health solutions, particularly digital therapies. The need for digital tools to manage and track medical issues has increased as people's awareness of their health has grown.

Growing Chronic Diseases: Chronic illnesses like diabetes, heart disease, and respiratory conditions are becoming more common in China. The industry is growing because digital therapies provide an accessible and affordable means of managing and treating these chronic illnesses.

Government Support: As part of its larger attempts to overhaul the healthcare system, the Chinese government has demonstrated support for digital health initiatives, particularly digital therapeutics. The market has benefited from laws and programs that encourage the use of digital technologies in healthcare.

Market Restraints:

Healthcare Professionals' Resistance: Adoption may be hampered by healthcare professionals' resistance or skepticism about the effectiveness and incorporation of digital treatments into conventional healthcare practices.

Healthcare Infrastructure: Certain regions may have inadequate infrastructure, which could restrict the market's growth. Widespread access to mobile devices, the internet, and electronic health records, is necessary for the adoption of digital treatments.

Reimbursement Difficulties: It may be difficult to establish digital therapy reimbursement mechanisms within the current healthcare reimbursement frameworks. Payers might be reluctant to cover the cost of these digital interventions.

Healthcare Policies and Regulatory Landscape

In China, the National Medical Products Administration (NMPA) is in charge of regulating medications and medical equipment. Drug approval processes usually involve the applicant filing a New Drug Application (NDA) with the NMPA. The NMPA conducts an on-site examination of the applicant's production facilities following its evaluation of the NDA. The NMPA has more stringent data requirements than other nations for clinical research, which might increase the cost and duration of the procedure.

Competitive Landscape

Key Players:

Alibaba Health
WeDoctor
Omada Health Inc.
2Morrow Inc.
Livongo Health Inc.
WellDoc
Propeller Health
Canary Health
Noom Inc.
Akili Interactive Labs Inc.
HYGIEIA

1. Executive Summary
1.1 Digital Health Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Digital Health Policy in Country
1.6 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

China Digital Therapeutics Market Segmentation

By Solution

Software
Services

By Deployment

Cloud-based
On-premises

By Application

Therapy
Diabetes
Obesity
CNS
Respiratory
CVD

By End-use

Diagnostic Centres
Healthcare Players
Healthcare Research Centres
Hospitals & Clinics
Nursing Care Centres
Others

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.